CARDIFF ONCOLOGY, INC. Sale of Stock, Price Per Share
CARDIFF ONCOLOGY, INC. (CRDF) had Sale of Stock, Price Per Share of $13.50 per share as of 2020-10-02, per its 10-K filed 2022-02-24.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2022-02-24
- 2020-10-02: Sale of Stock, Price Per Share $13.50.
- 2020-05-14: Sale of Stock, Price Per Share $1.43.
- 2020-05-11: Sale of Stock, Price Per Share $1.34.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2020-10-02 | $13.50 10-K · filed 2022-02-24 |
| 2020-05-14 | $1.43 10-K · filed 2022-02-24 |
| 2020-05-11 | $1.34 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |